You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 18 Feb 311.95 1.55
(0.50%)
OPEN

312.20

HIGH

313.40

LOW

303.60

NSE 00:00 | 18 Feb 311.95 1.55
(0.50%)
OPEN

312.30

HIGH

314.00

LOW

303.15

OPEN 312.20
PREVIOUS CLOSE 310.40
VOLUME 100301
52-Week high 667.00
52-Week low 267.30
P/E 6.84
Mkt Cap.(Rs cr) 8,803
Buy Price 307.90
Buy Qty 5.00
Sell Price 311.95
Sell Qty 288.00
OPEN 312.20
CLOSE 310.40
VOLUME 100301
52-Week high 667.00
52-Week low 267.30
P/E 6.84
Mkt Cap.(Rs cr) 8,803
Buy Price 307.90
Buy Qty 5.00
Sell Price 311.95
Sell Qty 288.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   8,803
EPS - TTM () [*S] 45.59
P/E Ratio (X) [*S] 6.84
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 19 Sep 2019
Dividend Yield (%) 0.64
Book Value / Share () [*S] 446.59
P/B Ratio () [*S] 0.70
[*C] Consolidated     [*S] Standalone    

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 2735.56 2555.05 7.06
Other Income 32.96 -109.02 130.23
Total Income 2768.52 2446.03 13.18
Total Expenses 2295.49 2120.37 8.26
Operating Profit 473.04 325.67 45.25
Net Profit 190.84 116.34 64.04
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alembic Pharma 645.65 0.31 12170.50
Natco Pharma 637.25 -4.24 11601.14
Ajanta Pharma 1293.00 -4.64 11281.43
Glenmark Pharma. 311.95 0.50 8803.23
Jubilant Life 496.60 -3.26 7910.84
Proc. Gam. Heal. 4240.70 0.83 7039.56
Astrazeneca Phar 2729.40 -0.51 6823.50
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.59
Banks/FIs 2.97
FIIs 30.16
Insurance 0.00
Mutual Funds 4.07
Indian Public 11.54
Custodians 0.00
Other 4.67
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -5.81% -5.80% -0.78% -0.95%
1 Month -13.38% -13.34% -2.51% -2.91%
3 Month -14.65% -14.66% 1.51% 0.91%
6 Month -13.61% -13.62% 9.49% 8.55%
1 Year -45.88% -45.95% 15.20% 12.70%
3 Year -67.06% -67.04% 43.65% 35.94%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 303.60
313.40
Week Low/High 303.60
346.00
Month Low/High 298.25
372.00
YEAR Low/High 267.30
667.00
All TIME Low/High 1.89
1262.00